EDAP TMS SA (EDAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EDAP TMS SA (EDAP) has a cash flow conversion efficiency ratio of -0.294x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.97 Million) by net assets ($10.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EDAP stock market capitalisation for the company's overall valuation and market capitalisation.
EDAP TMS SA - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how EDAP TMS SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
EDAP TMS SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EDAP TMS SA ranked by their cash flow conversion efficiency. Explore cash flow quality index of EDAP TMS SA to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fasadgruppen Group AB
ST:FG
|
0.124x |
|
Auna S.A.
NYSE:AUNA
|
0.052x |
|
Arrowmark Financial Corp
NASDAQ:BANX
|
0.048x |
|
Pyrum Innovations AG
OL:PYRUM
|
-0.116x |
|
Digital Currency X Technology Inc.
NASDAQ:DCX
|
-0.005x |
|
Sea Sonic Electronics Co Ltd
TWO:6203
|
0.030x |
|
Bulten AB
ST:BULTEN
|
0.027x |
|
Trivago NV
NASDAQ:TRVG
|
0.091x |
Annual Cash Flow Conversion Efficiency for EDAP TMS SA (1997–2025)
The table below shows the annual cash flow conversion efficiency of EDAP TMS SA from 1997 to 2025. View current stock price of EDAP TMS SA for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.41 Million | $-16.41 Million | -0.845x | -154.47% |
| 2024-12-31 | $40.90 Million | $-13.58 Million | -0.332x | -28.82% |
| 2023-12-31 | $56.92 Million | $-14.68 Million | -0.258x | -510.79% |
| 2022-12-31 | $71.63 Million | $-3.02 Million | -0.042x | -147.54% |
| 2021-12-31 | $50.05 Million | $4.45 Million | 0.089x | +3.42% |
| 2020-12-31 | $26.25 Million | $2.25 Million | 0.086x | -38.18% |
| 2019-12-31 | $27.36 Million | $3.80 Million | 0.139x | +1881.34% |
| 2018-12-31 | $24.96 Million | $175.00K | 0.007x | +105.77% |
| 2017-12-31 | $25.16 Million | $-3.06 Million | -0.122x | -365.69% |
| 2016-12-31 | $24.45 Million | $1.12 Million | 0.046x | -50.64% |
| 2015-12-31 | $14.43 Million | $1.34 Million | 0.093x | +238.45% |
| 2014-12-31 | $15.14 Million | $-1.01 Million | -0.067x | +75.08% |
| 2013-12-31 | $9.28 Million | $-2.50 Million | -0.269x | -1253.83% |
| 2012-12-31 | $8.16 Million | $-162.00K | -0.020x | +76.53% |
| 2011-12-31 | $8.71 Million | $-737.00K | -0.085x | +80.28% |
| 2010-12-31 | $8.90 Million | $-3.82 Million | -0.429x | -47.28% |
| 2009-12-31 | $12.58 Million | $-3.66 Million | -0.291x | -9.02% |
| 2008-12-31 | $17.19 Million | $-4.59 Million | -0.267x | -41.95% |
| 2007-12-31 | $14.52 Million | $-2.73 Million | -0.188x | -91.08% |
| 2006-12-31 | $19.30 Million | $-1.90 Million | -0.099x | -500.94% |
| 2005-12-31 | $17.36 Million | $-284.53K | -0.016x | +74.02% |
| 2004-12-31 | $17.95 Million | $-1.13 Million | -0.063x | +67.23% |
| 2003-12-31 | $18.93 Million | $-3.64 Million | -0.192x | +31.41% |
| 2002-12-31 | $28.40 Million | $-7.97 Million | -0.281x | -221.04% |
| 2001-12-31 | $38.98 Million | $-3.41 Million | -0.087x | -10295.04% |
| 2000-12-31 | $34.78 Million | $29.81K | 0.001x | +100.52% |
| 1999-12-31 | $15.47 Million | $-2.54 Million | -0.164x | +36.19% |
| 1998-12-31 | $24.90 Million | $-6.39 Million | -0.257x | -2288.70% |
| 1997-12-31 | $33.82 Million | $-363.64K | -0.011x | -- |
About EDAP TMS SA
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more